Results

Total Results: over 10,000 records

Showing results for "days".

101. PowerPoint Presentation: Best Practices in the Diagnosis and Treatment of Asymptomatic Bacteriuria and Urinary Tract Infections
     www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/best-practices/ASB-UTI-slides.pptx
     November 01, 2019 - Moment 4: Duration 17 Drug Duration Studied Nitrofurantoin 5 days TMP/SMX 3 days Cefaclor 5 days … Cefpodoxime 3 days Cephalexin 7 days Cefdinir 5 days ASB and UTI AHRQ Safety Program for … Moment 4: Duration Fluoroquinolones: 5–7 days total therapy TMP/SMX: 10–14 days total therapy Oral … Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated … Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label

102. PowerPoint Presentation
     www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/best-practices/gastro-slides.pptx
     November 01, 2019 - RCT in which patients were randomized at day 4 to stop therapy or continue for 3 more days showed 94% … vs 96% cure at one month8 Complicated:5,9 Medical management: suggest 5–10 days based on clinical … or up to 10 days (median was 8) of antibiotic therapy after source control10 Primary outcome: surgical … Time to diagnosis of recurrent intra-abdominal process: 11 vs. 15 days 16 From N Eng J Med, Sawyer … Median 15 days Short course 6–10 days Median 8 days Propensity score matching resulted in 385 well

103. Culture Measures | Agency for Healthcare Research and Quality
     www.ahrq.gov/hai/cusp/cauti-interim/cauti-interim4b.html
     July 01, 2013 - Catheter Utilization Ratio During Baseline (BL) and Post-Baseline (P) Collection Periods – (Catheter Days … /Patient Days) Note: n's represent the total number of reporting units for corresponding collection … Ratio During Baseline (BL) and Post-Baseline (P) Collection Periods – By Cohort Status – (Catheter Days … /Patient Days) Note: n's represent the total number of reporting units for corresponding cohorts … /Patient Days) Note: n's represent the total number of reporting units for corresponding bed sizes

104. Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-148-section-2-tech-specs.pdf
     June 02, 2025 - Negative Medication History A period of 120 days (4 months) prior to the IPSD when the member had … Continuous enrollment 120 days (4 months) prior to the IPSD through 30 days after the IPSD. … Members must be continuously enrolled for 120 days (4 months) prior to the IPSD through 30 days after … with or without a telehealth modifier (Telehealth Modifier Value Set) in the 121-day period from 90 days … prior to the IPSD through 30 days after the IPSD.

105. Choosing a Stewardship Intervention and Measuring Change (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/long-term-care/intervention-worksheet.pdf
     June 01, 2021 - o Metrics to consider tracking over time include:  Number of antibiotic starts per 1,000 resident days …  Days of antibiotic therapy per 1,000 resident days  Median length of antibiotic therapy  Use … of guideline-concordant antibiotics  Clostridioides difficile LabID events per 10,000 resident days … data for both the numerator (e.g., number of antibiotic starts) and the denominator (e.g., resident days

106. Management of Clostridioides Difficile Infection (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/long-term-care/one-pager-clostridioides-difficile.pdf
     June 01, 2021 - − Do not repeat testing within 7 days. − Do not perform tests of cure. … Oral vancomycin (125 mg orally [PO] 4 times a day) or fidaxomicin (200 mg PO 2 times a day) for 10 days … vancomycin or fidaxomicin is limited, consider oral metronidazole (500 mg PO 3 times a day) for 10 days … OR tapered oral vancomcyin (125 mg PO 4 times a day for 10–14 days, 2 times per day for 7 days, 1 time … per day for 7 days, every 2–3 days for 2–8 weeks).

107. CHIPRA 207: Section 7, Table 13 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-207-section-7-table-13.pdf
     June 02, 2025 - Readmission Rates Stratified by Special Healthcare Needs Status by Year Readmission 7 Days Rate (CL … ) Readmission 14 Days Rate (CL) Readmission 30 Days Rate (CL) Readmission 90 Days Rate (CL) … Readmission 365 Days Rate (CL) 1995 Healthy 0.016 (0.014-0.018) 0.021 (0.018-0.023) 0.031 (0.028

108. Medical Expenditure Panel Survey What's New
     meps.ahrq.gov/mepsweb/communication/whats_new.jsp
     August 28, 2025 - New at MEPS E-mail Updates See What's New archive Last 60 days … Last 90 days Last 120 days Last 150 days Last 180 days Show All Current Month Previous … Month -------------------- Last 30 days New Web site postings in the last … 30 days Data MEPS HC-251: 2023 Full

109. On-Time Preventable Hospital and ED Visits Functional Specs (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/long-term-care/resources/ontime/prevhosp/prevhospitalvisits-funcspecs_0.pdf
     August 01, 2017 - Count the number of ED visits within 0-7 days of report date and display sum total. 2 8-30 days ( … Count the number of ED visits within 8-30 days of report date and display sum total. 3 31-90 days … Count the number of admissions within 0-7 days of report date and display sum total. 7 8-30 days … Count the number of admissions within 8-30 days of report date and display sum total. 8 31-90 days … IF “Hospital Admission History <30 Days” OR “Hospital Admission History 31-90 Days” contains a count

110. Monitoring Ventilator-Associated Events Module 2
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/mvp/modules/vae/monitoring-vae-slides.pptx
     January 01, 2017 - Increases hospital length of stay by 14 days Impact of Ventilator-Associated Pneumonia4,7-12 4. … The change is maintained or worsens for ≥ 2 days. Is this a VAC? … The change is maintained or worsens for ≥ 2 days. Is this a VAC? YES! This is a VAC! … The change is maintained or worsens for ≥ 2 days. Is this a VAC? … The change is maintained or worsens for ≥ 2 days. Is this a VAC? YES! This is a VAC!

111. Final Progress Report: Central Venous Catheter (CVC)–Related Bloodstream Infections in Pediatric Cancer (pdf file)
     www.ahrq.gov/sites/default/files/2024-09/secola-report.pdf
     January 01, 2024 - Results: There were two CVC-related BSIs/682 catheter days in the EU group (2.94/1000 catheter days) … versus three CVC-related BSIs/900 catheter days in the CU group (3.33/1000 catheter days; P = 0.63). … days per admission. … Monthly rates of CVC-related BSIs per 1000 catheter days were recorded by unit. … on the unit and reported as BSIs per 1000 days with 95% CIs.

112. Sickle Cell Disease, Measure 1: Timeliness of Confirmatory Testing for Sickle Cell Disease (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-132-scd-section-2.pdf
     October 01, 2013 - with a newborn screen positive for sickle cell disease (SCD) who received confirmatory testing by 90 days … of age, with results of confirmatory testing communicated by 120 days of age. … Numerators Testing Eligible children who received confirmatory testing ≤90 days of age. … Results Eligible children with results of confirmatory testing communicated ≤120 days of age. … Exclusions  Children who died within 120 days of birth.

113. AHRQ’s Safety Program for Nursing Homes: On-Time Preventable Hospital and Emergency Department Visits - Functional Specifications (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/long-term-care/resources/ontime/fallsprev/ontimefallspxspecs.pdf
     February 01, 2018 - days of report date, then display X. … If J1700 A = 1 and MDS A2300 <7 days of report date, then display X. 25 HREC 3B (Fall 31-180 Days … 31-180 days of report date, then display X. … New Contributing Risk Factor Within 7 Days Additional Information Within 30 Days Injury Totals … Date The system determine days of week from fall date.

114. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/60593/psn-pdf
     June 17, 2020 - Failure to follow medication changes made at hospital discharge is associated with adverse events in 30 days … Failure to follow medication changes made at hospital discharge is associated with adverse events in 30 days … psnet.ahrq.gov/issue/failure-follow-medication-changes-made-hospital-discharge-associated- adverse-events-30-days … At 30-days post-discharge, nearly half of patients were nonadherent to at least one medication change … who were non-adherent to all medication changes had a 35% higher risk of adverse events within 30-days

115. Best Practices in the Diagnosis and Treatment of Asymptomatic Bacteriuria and Urinary Tract Infections – Facilitator Guide (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/ambulatory-care/uti-guide.docx
     September 01, 2022 - If prescribing nitrofurantoin, 5 days is generally sufficient. … For trimethoprim-sulfamethoxazole, 3 days is sufficient. … In randomized controlled trials, 7 days of ciprofloxacin and 5 days of 750 mg of levofloxacin have been … and 10 days for oral cephalosporins may be sufficient. … susceptibility results are available within 2–3 days.

116. Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
     March 01, 2024 - Serious adverse events, convalescent plasma, 45 days or less Serious Adverse Event Study ID Days … Serious adverse events, convalescent plasma, more than 45 days Serious Adverse Event Study ID Days … Timing ranged from 7 to 29 days. … Serious adverse events, more than 45 days, sotrovimab Serious Adverse Event Study ID Days n/N … Serious adverse events, tocilizumab, more than 45 days Serious Adverse Event Study ID Days n/N

117. Hcup Formats
     hcup-us.ahrq.gov/db/tools/HCUP_Formats.TXT
     December 28, 2023 - 10 days" 11 - 30 = " 11 - 30 days" 31 - 60 = " 31 - 60 days" … 5 days" 6 = " 6 days" 7 = " 7 days" … days" 121 - 150 = " 121 - 150 days" 151 - 180 = " 151 - 180 days" … days" 31 - 60 = " 31 - 60 days" 61 - 90 = " 61 - 90 days" … 10 days" 11 - 20 = " 11 - 20 days" 21 - 50 = " 21 - 50 days"

118. Urinary Tract Infections (UTI) (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/best-practices/UTI-one-page.docx
     November 01, 2019 - recommendations here] Duration Uncomplicated acute cystitis Nitrofurantoin or cephalosporin: 5 days … Trimethoprim/sulfamethoxazole (TMP/SMX): 3 days Uncomplicated pyelonephritis Fluoroquinolone: 5–7 … days TMP/SMX or oral cephalosporin:10–14 days (shorter course if early response) Complicated UTI … (including CAUTI) 3 days if lower tract CAUTI in women ≤ 65 years if catheter is removed/not replaced … 7 days if prompt resolution of symptoms 10–14 days if delayed response, obstruction, or other urologic

119. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/74725/psn-pdf
     February 02, 2022 - A retrospective audit of postoperative days alive and out of hospital, including before and after implementation … A retrospective audit of postoperative days alive and out of hospital, including before and after implementation … https://psnet.ahrq.gov/issue/retrospective-audit-postoperative-days-alive-and-out-hospital-including-and … In this study, postoperative mortality and increased days alive and out of hospital were measures for … Changes in mortality and days alive and out of hospital during these time periods were indistinguishable

120. PowerPoint Presentation
     www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/long-term-care/tracking-measuring-data-slides.pptx
     June 01, 2021 - Days of antibiotic therapy 2. … tracking if the facility does not already have an established method Form tracks the following: Antibiotic days … residents received a particular antibiotic In this example, the resident received 5 days of therapy … Thursday Friday Morning dose X X X X Afternoon dose X X X X Evening dose X X X X 6 Antibiotic Days … of Therapy Tracking and Measuring 6 Antibiotic Days of Therapy 7 Tracking and Measuring 7